The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis


Serban M. Maierean | Maria-Corina Serban, MD, PhD | Amirhossein Sahebkar, PharmD, PhD | Sorin Ursoniu, MD, PhD | Alexandru Serban, PhD | Peter Penson, MPharm, PhD | Maciej Banach, MD, PhD | on behalfthe Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
First published: August 11, 2017 |



Cinnamon is a rich botanical source of polyphenols, whose positive effects on blood lipid concentrations have been hypothesized, but have not been conclusively studied.


The objective of the study was to systematically review and evaluate the effect of administration of cinnamon on blood lipid concentrations.


We assessed 13 randomized controlled trials with 750 participants investigating the effect of cinnamon supplementation on blood lipid concentrations. A meta-analysis was performed using random effect models, with weighted mean differences (WMDs; with 95% confidence interval [CI]) for endpoints calculated using a random effects model.


No statistically significant effect of cinnamon was observed on blood low-density lipoprotein cholesterol (LDL-C; WMD: −0.16 mmol/L [−6.19 mg/dL], 95% CI: −0.35, 0.03 [−13.53, 1.16], P = .10) and high-density lipoprotein cholesterol (HDL-C; WMD: 0.05 mmol/L [1.92 mg/dL], 95% CI: −0.03, 0.12 [−0.03, 4.64], P = .21) concentrations. However, a statistically significant reduction in blood triglycerides (WMD: −0.27 mmol/L [−23.91 mg/dL], 95% CI: −0.39, −0.14 [−34.54, −12.40], P < .01) and total cholesterol concentrations (WMD: −0.36 mmol/L [−13.92 mg/dL], 95% CI: −0.63, −0.09 [−24.36, −3.48], P < .01) was observed. HDL-C was significantly elevated after the omission of 1 study (WMD: 0.04 mmol/L [1.54 mg/dL], 95% CI: 0.03, 0.06 [1.16, 2.32], P < .01) during our sensitivity analysis. A meta-regression analysis was conducted, and no significant association was found between changes in lipid parameters and cinnamon dose. In contrast, changes in blood levels of total cholesterol (slope: 0.09; 95% CI: 0.02, 0.16; P < .01), LDL-C (slope: 0.05; 95% CI: 0.001, 0.10; P = .05) and triglycerides (slope: 0.06; 95% CI: 0.04, 0.09; P < .01) were significantly and positively associated with the duration of supplementation. No statistically significant association was found between blood HDL-C changes and duration of supplementation.


Cinnamon supplementation significantly reduced blood triglycerides and total cholesterol concentrations without any significant effect on LDL-C and HDL-C.

  1. Chait A., Eckel R.H.
    Lipids, lipoproteins, and cardiovascular disease: clinical pharmacology now and in the future.
    J Clin Endocrinol Metab. 2016; 101: 804-814
  2. Cicero A.F., Tartagni E., Ertek S.
    Nutraceuticals for metabolic syndrome management: from laboratory to benchside.
    Curr Vasc Pharmacol. 2014; 12: 565-571
  3. Pirro M., Mannarino M.R., Bianconi V., et al.
    The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials.
    Pharmacol Res. 2016; 110: 76-88
  4. Food and Drug Administration
    Withdrawal of approval of indications related to the coadministration with statins in applications for niacin extended-release tablets and fenofibric acid delayed-release capsules.
    Fed Regist. 2016; (FDA Notice No. 2016-08887, effective date: 04/18/2016, pp. 22612-22613)
  5. Ranasinghe P., Pigera S., Premakumara G.A., et al.
    Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review.
    BMC Complement Altern Med. 2013; 13: 275
  6. Ranasinghe P., Galappaththy P.
    Health benefits of Ceylon cinnamon (Cinnamomum zeylanicum): a summary of the current evidence.
    Ceylon Med J. 2016; 61: 1-5
  7. Kumar K., Issac A., Ninan E., Kuttan R., Maliakel B.
    Enhanced anti-diabetic activity of polyphenol-rich de-coumarinated extracts of Cinnamomum cassia.
    J Funct Foods. 2014; 10: 10
  8. Kawatra P., Rajagopalan R.
    Cinnamon: mystic powers of a minute ingredient.
    Pharmacognosy Res. 2015; 7: S1-S6
  9. Archer A.W.
    Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography.
    J Chromatogr. 1988; 447: 5
  10. Gruenwald J., Freder J., Armbruester N.
    Cinnamon and health.
    Crit Rev Food Sci Nutr. 2010; 50: 822-834
  11. Jayaprakasha G.K., Rao L.J.
    Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum.
    Crit Rev Food Sci Nutr. 2011; 51: 547-562
  12. Medagama A.B.
    The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials.
    Nutr J. 2015; 14: 108
  13. Higgins JPT and Green S, (Eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at:
  14. Borenstein M., Hedges L., Higgins J., Rothstein H.
    Comprehensive Meta-Analysis, Version 2.
    Biostat, Englewood, NJ2005 (104)
  15. Akilen R., Tsiami A., Devendra D., Robinson N.
    Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial.
    Diabet Med. 2010; 27: 1159-1167
  16. Anderson R.A., Zhan Z., Luo R., et al.
    Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose.
    J Tradit Complement Med. 2015; 30: 5
  17. Askari F., Rashidkhani B., Hekmatdoost A.
    Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Nutr Res. 2014; 34: 143-148
  18. Blevins S.M., Leyva M.J., Brown J., Wright J., Scofield R.H., Aston C.E.
    Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes.
    Diabetes Care. 2007; 30: 2236-2237
  19. Khan A., Safdar M., Ali Khan M.M., Khattak K.N., Anderson R.A.
    Cinnamon improves glucose and lipids of people with type 2 diabetes.
    Diabetes Care. 2003; 26: 3215-3218
  20. Lu T., Sheng H., Wu J., Cheng Y., Zhu J., Chen Y.
    Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes.
    Nutr Res. 2012; 32: 408-412
  21. Mang B., Wolters M., Schmitt B., et al.
    Effects of a cinnamon extract on blood glucose, HbA, and serum lipids in diabetes mellitus type 2.
    Eur J Clin Invest. 2006; 36: 340-344
  22. Sengsuk C., Sanguanwong S., Tangvarasittichai O., Tangvarasittichai S.
    Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitus.
    Diabetol Int. 2015; 7: 124-132
  23. Vafa M., Mohammadi F., Shidfar F., et al.
    Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients.
    Int J Prev Med. 2012; 3: 531-536
  24. Vanschoonbeek K., Thomassen B.J., Senden J.M., Wodzig W.K., van Loon L.J.
    Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.
    J Nutr. 2006; 136: 977-980
  25. Wickenberg J., Lindstedt S., Berntorp K., Nilsson J., Hlebowicz J.
    Ceylon cinnamon does not affect postprandial blood glucose or insulin in subjects with impaired glucose tolerance.
    Br J Nutr. 2012; 107: 1845-1849
  26. Zahmatkesh M., Fallah Huseini H., Hajiaghaee R., Heidari M., Mehrafarin A., Tavakoli-Far B.
    The effects of Cinnamomum zeylancium on blood glucose level in patients with type 2 diabetes, a double-blind clinical trial.
    J Med Plants. 2012; 1: 6
  27. Ziegenfuss T.N., Hofheins J.E., Mendel R.W., Landis J., Anderson R.A.
    Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women.
    J Int Soc Sports Nutr. 2006; 3: 45-53
  28. Banach M., Rizzo M., Toth P.P., et al.
    Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
    Arch Med Sci. 2015; 11: 1-23
  29. Finegold J.A., Manisty C.H., Goldacre B., Barron A.J., Francis D.P.
    What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.
    Eur J Prev Cardiol. 2014; 21: 464-474
  30. Reith C., Armitage J.
    Management of residual risk after statin therapy.
    Atherosclerosis. 2016; 245: 161-170
  31. Mancini G.B., Tashakkor A.Y., Baker S., et al.
    Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Can J Cardiol. 2013; 29: 1553-1568
  32. Banach M., Aronow W.S., Serban M.C., Rysz J., Voroneanu L., Covic A.
    Lipids, blood pressure and kidney update 2015.
    Lipids Health Dis. 2015; 14: 167
  33. Sahebkar A., Serban M.C., Gluba-Brzózka A., et al.
    Lipid-modifying effects of nutraceuticals: an evidence-based approach.
    Nutrition. 2016; 32: 1179-1192
  34. Serban M.C., Sahebkar A., Dragan S., et al.
    A systematic review and meta-analysis of the impact of Spirulina supplementation on blood lipid concentrations.
    Clin Nutr. 2015; 35: 842-851
  35. Ursoniu S., Sahabkar A., Serban M.C., et al.
    Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials.
    Arch Med Sci. 2015; 11: 253-266
  36. Baker W.L., Gutierrez-Williams G., White C.M., Kluger J., Coleman C.I.
    Effect of cinnamon on glucose control and lipid parameters.
    Diabetes Care. 2008; 31: 41-43
  37. Allen R.W., Schwartzman E., Baker W.L., Coleman C.I., Phung O.J.
    Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis.
    Ann Fam Med. 2013; 11: 452-459
  38. Solomon T.P., Blannin A.K.
    Effects of short-term cinnamon ingestion on in vivo glucose tolerance.
    Diabetes Obes Metab. 2007; 9: 895-901
  39. Kim S.H., Choung S.Y.
    Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice.
    Arch Pharm Res. 2010; 33: 325-333
  40. Ranasinghe P., Jayawardana R., Galappaththy P., Constantine G.R., de Vas Gunawardana N., Katulanda P.
    Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.
    Diabet Med. 2012; 29: 1480-1492
  41. Konig B., Koch A., Spielmann J., Hilgenfeld C., Stangl G.I., Eder K.
    Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.
    Biochem Pharmacol. 2007; 73: 574-585
  42. Abraham K., Wöhrlin F., Lindtner O., Heinemeyer G., Lampen A.
    Toxicology and risk assessment of coumarin: focus on human data.
    Mol Nutr Food Res. 2010; 54: 228-239
  43. Blahova J., Svobodova Z.
    Assessment of coumarin levels in ground cinnamon available in the Czech retail market.
    ScientificWorldJournal. 2012; 2012: 263851
  44. Brancheau D., Patel B., Zughaib M.
    Do cinnamon supplements cause acute hepatitis?.
    Am J Case Rep. 2015; 16: 250-254